Riedl MA - Search Results

1

Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study.

Banerji A, Bernstein JA, Johnston DT, Lumry WR, Magerl M, Maurer M, Martinez-Saguer I, Zanichelli A, Hao J, Inhaber N, Yu M, Riedl MA; HELP OLE Investigators. Banerji A, et al. Among authors: riedl ma. Allergy. 2022 Mar;77(3):979-990. doi: 10.1111/all.15011. Epub 2021 Aug 13. Allergy. 2022. PMID: 34287942 Free PMC article. Clinical Trial.

2

Update on the acute treatment of hereditary angioedema.

Riedl MA. Riedl MA. Allergy Asthma Proc. 2011 Jan-Feb;32(1):11-6. doi: 10.2500/aap.2011.32.3406. Allergy Asthma Proc. 2011. PMID: 21262093 Review.

3

Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.

Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, Reshef A, Zuraw B; HAWK (Hereditary Angioedema International Working Group). Cicardi M, et al. Allergy. 2012 Feb;67(2):147-57. doi: 10.1111/j.1398-9995.2011.02751.x. Epub 2011 Nov 30. Allergy. 2012. PMID: 22126399

4

Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.

Riedl MA, Hurewitz DS, Levy R, Busse PJ, Fitts D, Kalfus I. Riedl MA, et al. Ann Allergy Asthma Immunol. 2012 Jan;108(1):49-53. doi: 10.1016/j.anai.2011.10.017. Epub 2011 Nov 21. Ann Allergy Asthma Immunol. 2012. PMID: 22192966 Clinical Trial.

5

HAE update: special considerations in the female patient with hereditary angioedema.

Geng B, Riedl MA. Geng B, et al. Among authors: riedl ma. Allergy Asthma Proc. 2013 Jan-Feb;34(1):13-8. doi: 10.2500/aap.2013.34.3635. Allergy Asthma Proc. 2013. PMID: 23406930 Review.

6

Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women.

Baker JW, Craig TJ, Riedl MA, Banerji A, Fitts D, Kalfus IN, Uknis ME. Baker JW, et al. Among authors: riedl ma. Allergy Asthma Proc. 2013 Mar-Apr;34(2):162-9. doi: 10.2500/aap.2013.34.3645. Allergy Asthma Proc. 2013. PMID: 23484892 Clinical Trial.

7

Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.

Riedl MA, Levy RJ, Suez D, Lockey RF, Baker JW, Relan A, Zuraw BL. Riedl MA, et al. Ann Allergy Asthma Immunol. 2013 Apr;110(4):295-9. doi: 10.1016/j.anai.2013.02.007. Epub 2013 Mar 6. Ann Allergy Asthma Immunol. 2013. PMID: 23535096 Clinical Trial.

8

Creating a comprehensive treatment plan for hereditary angioedema.

Riedl MA. Riedl MA. Immunol Allergy Clin North Am. 2013 Nov;33(4):471-85. doi: 10.1016/j.iac.2013.07.003. Epub 2013 Aug 26. Immunol Allergy Clin North Am. 2013. PMID: 24176212 Review.

9

Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.

Riedl MA, Lumry WR, Li HH, Craig TJ, Fitts D, Kalfus I, Uknis ME. Riedl MA, et al. Am J Rhinol Allergy. 2013 Nov-Dec;27(6):517-21. doi: 10.2500/ajra.2013.27.3973. Am J Rhinol Allergy. 2013. PMID: 24274230

10

Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial.

Riedl MA, Bernstein JA, Li H, Reshef A, Lumry W, Moldovan D, Farkas H, Levy R, Baker J, Hardiman Y, Totoritis MC, Relan A, Cicardi M; Study 1310 Investigators. Riedl MA, et al. Ann Allergy Asthma Immunol. 2014 Feb;112(2):163-169.e1. doi: 10.1016/j.anai.2013.12.004. Epub 2014 Jan 7. Ann Allergy Asthma Immunol. 2014. PMID: 24468257 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters